Skip to main content

Table 1 Clinicopathological characteristics of pancreatic cancer patients

From: RETRACTED ARTICLE: miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer

Parameter   eEF1A2 protein miR-663
   Expression level P value Expression level P value
Gender      
  Male 45 0.706 ± 0.1486 0.230 0.421 ± 0.2493 0.426
  Female 23 0.750 ± 0.1272   0.374 ± 0.1669  
Age (years)      
  <60 42 0.702 ± 0.1515 0.163 0.422 ± 0.2552 0.436
  ≥60 26 0.751 ± 0.1227   0.378 ± 0.1649  
Diameter (cm)      
  <3 51 0.715 ± 0.1471 0.566 0.425 ± 0.2322 0.218
  ≥3 17 0.738 ± 0.1294   0.347 ± 0.1947  
Location      
  Head 48 0.713 ± 0.1394 0.486 0.398 ± 0.2057 0.663
  Body, tail 20 0.739 ± 0.1511   0.423 ± 0.2696  
Differentiation      
  Well 13 0.643 ± 0.1667   0.518 ± 0.3358  
  Moderate 39 0.735 ± 0.1265 0.086 0.383 ± 0.1812 0.124
  Poor 16 0.747 ± 0.1453   0.366 ± 0.1947  
TNM stage      
  I-II 30 0.670 ± 0.1635 0.009* 0.498 ± 0.2742 0.004*
  III-IV 38 0.760 ± 0.1098   0.332 ± 0.1411  
Nodal status      
  Negative 36 0.688 ± 0.1632 0.048* 0.464 ± 0.2623 0.017*
  Positive 32 0.757 ± 0.1057   0.338 ± 0.1505  
  1. *Indicated statistical significance (P < 0.05).